Syncope, a transient loss of consciousness due to global cerebral hypoperfusion, is a medical condition that often presents a diagnostic challenge. This article aims to provide healthcare professionals with a comprehensive approach to understanding, diagnosing, and managing syncope.
Syncope is a symptom, not a diagnosis, and its underlying causes can be diverse, ranging from benign to life-threatening. It accounts for approximately 1% of all emergency department visits. The common causes are neurocardiogenic, orthostatic hypotension, and cardiac syncope. However, about 50% of the time, the cause remains unknown, termed as unexplained syncope.
The diagnosis of syncope begins with a detailed history and physical examination. The goal is to identify any potential triggers, prodromal symptoms, and the circumstances surrounding the event. Special attention should be given to cardiac history. Diagnostic tests such as electrocardiogram (ECG), Holter monitoring, echocardiography, and tilt-table testing can be used based on clinical suspicion. However, over-reliance on diagnostic tests without a clear clinical indication can lead to unnecessary costs and potential harm to patients.
The management of syncope is primarily directed towards the underlying cause. In cases of unexplained syncope, the focus should be on risk stratification and patient education. Non-pharmacological interventions such as physical counter-pressure manoeuvres can be effective. Pharmacological treatment options are limited and should be considered only when non-pharmacological interventions are ineffective or not feasible. In patients with high-risk features, more invasive strategies such as pacemaker or implantable cardioverter-defibrillator (ICD) may be considered.
Understanding, diagnosing, and managing syncope requires a comprehensive, patient-centred approach. While the diagnostic journey can be challenging, a systematic approach can help in identifying the underlying cause and appropriate management. Ongoing research in this field promises to shed more light on the enigmatic nature of syncope and improve patient outcomes.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation